Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Other 1

Conditions

Polycystic Ovary Syndrome 2Obesity 1Adenocarcinoma of Lung 1

Interventions

Cisplatin 1519Carboplatin 1420Cyclophosphamide 1360Gemcitabine 1235Bevacizumab 1226Paclitaxel 1211Radiotherapy 1176Docetaxel 1080pembrolizumab 1028Oxaliplatin 936Capecitabine 901Fluorouracil 833Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 666Etoposide 660Irinotecan 622Leucovorin 575Pemetrexed 510Drug Therapy 493Cetuximab 483Trastuzumab 469Cytarabine 466Magnetic Resonance Spectroscopy 458Filgrastim 446Prednisone 433Lenalidomide 409Specimen Handling 408Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Orlistat × Clear all
NCT06818955 2025-02-12

OOTER

Tongji Hospital

Phase 2 Not yet recruiting
36 enrolled
Thoracic

Adenocarcinoma of Lung

NCT01003483 2021-04-01

Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) Patients

Yazd Research & Clinical Center for Infertility

Phase 2 Completed
80 enrolled
Other

Obesity, Polycystic Ovary Syndrome

NCT00704912 2016-11-07

OWL-PCOS

Milton S. Hershey Medical Center

Phase 2 Completed
217 enrolled 16 charts

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡